Zic1 Antibodies

Santa Cruz Biotechnology delivers a wide array of Zic1 monoclonal antibodies for advanced research in developmental biology and neurogenesis. Zic1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Zic1, a member of the Zic family of zinc finger proteins, plays a crucial role in the regulation of gene expression during embryonic development and is involved in the differentiation of neural progenitor cells. Its importance extends to various physiological processes, including the development of the central nervous system and the maintenance of neural stem cells. Dysregulation of Zic1 has been implicated in several neurological disorders, making it a significant target for research. Researchers worldwide utilize Zic1 monoclonal antibodies to explore neural development pathways and investigate potential therapeutic approaches. Understanding Zic1's molecular mechanisms can lead to breakthroughs in treating developmental and neurological conditions. Current studies focusing on Zic1 continue to reveal new aspects of neural development and stem cell regulation. Santa Cruz Biotechnology monoclonal antibodies support the scientific community by enabling precise investigation of Zic1's role in neural development and disease mechanisms.